相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulation of vascular tone homeostasis by NO and H2S: Implications in hypertension
Sevda Gheibi et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Pharmacokinetics and Tissue Distribution Kinetics of Puerarin in Rats Using Indirect Competitive ELISA
Hui Kong et al.
MOLECULES (2017)
REM sleep deprivation induces endothelial dysfunction and hypertension in middle-aged rats: Roles of the eNOS/NO/cGMP pathway and supplementation with L-arginine
Jiaye Jiang et al.
PLOS ONE (2017)
Puerarin Improves Vascular Insulin Resistance and Cardiovascular Remodeling in Salt-Sensitive Hypertension
Chunxiang Tan et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2017)
Endothelial dysfunction in human essential hypertension
Ify Mordi et al.
JOURNAL OF HYPERTENSION (2016)
Extending the translational potential of targeting NO/cGMP-regulated pathways in the CVS
Andreas Papapetropoulos et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Clinical Significance of Endothelial Dysfunction in Essential Hypertension
Eugenia Gkaliagkousi et al.
CURRENT HYPERTENSION REPORTS (2015)
Significance of nitric oxide synthases: Lessons from triple nitric oxide synthases null mice
Masato Tsutsui et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2015)
Deciphering the Binding of Caveolin-1 to Client Protein Endothelial Nitric-oxide Synthase ( eNOS)
Andy E. Trane et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Puerarin: A Review of Pharmacological Effects
Yan-Xi Zhou et al.
PHYTOTHERAPY RESEARCH (2014)
Angiotensin II Impairs Endothelial Nitric-oxide Synthase Bioavailability under Free Cholesterol-enriched Conditions via Intracellular Free Cholesterol-rich Membrane Microdomains
Eisuke Amiya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Cardiovascular Therapeutics Targets on the NO–sGC–cGMP Signaling Pathway: A Critical Overview
Paulo Roberto B. Evora et al.
CURRENT DRUG TARGETS (2012)
eNOS gene delivery prevents hypertension and reduces renal failure and injury in rats with reduced renal mass
Sebastien Savard et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Role of the spinal cord NO/cGMP pathway in the control of arterial pressure and heart rate
Joao Paulo J. Sabino et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2011)
Puerarin Inhibits C-Reactive Protein Expression via Suppression of Nuclear Factor κB Activation in Lipopolysaccharide-Induced Peripheral Blood Mononuclear Cells of Patients with Stable Angina Pectoris
Xiangjun Yang et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2010)
The role of caveolin-1 in cardiovascular regulation
A. Rahman et al.
ACTA PHYSIOLOGICA (2009)
Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase
Annemarieke E. Loot et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
NADPH Oxidases, Reactive Oxygen Species, and Hypertension Clinical implications and therapeutic possibilities
Tamara M. Paravicini et al.
DIABETES CARE (2008)
Arterial remodeling and plasma volume expansion in caveolin-1-deficient mice
Sebastian Albinsson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Worldwide epidemic of hypertension
Arun Chockalingam et al.
CANADIAN JOURNAL OF CARDIOLOGY (2006)
Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric Oxide/cGMP signaling
H Mollnau et al.
CIRCULATION RESEARCH (2002)
Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice
M Drab et al.
SCIENCE (2001)
分享论文
